WANBURY · Health Care · 2026-08-21

Wanbury Ltd

3.3WatchWeak -0.2Stage 2 · wk 18In scan: Pullback Hunter · Prop ScanMARKET: BULL RISING · 2026-08-21
₹264.9
-1.36% today
₹926 Cr · Small cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Visit company website →
P/E (TTM)
15.7
Forward —
vs 52W High
-23.2%
₹163.3 lo₹344.8 hi
23.2% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 18
1w13w26w
Week 18 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
3.7%
200 DMA: ₹255.3 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.19x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -11.9% vs MA50 +0.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #55 of 84 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #39 of 58 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 34w
S2 34w
S3 14w
S4 14w
S2 18w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 5w → S2 8w → S3 1w → S2 34w → S3 5w → S2 34w → S3 5w → S4 5w → S1 4w → S2 11w → S3 14w → S4 14w → S1 8w → S2 18w current
Total tracked: 168 weeks across 14 stage runs.
1M
-19.6%
3M
-6.6%
6M
+4.8%
YTD
+13.4%
1Y
+6.2%
Scan Membership
Pullback Hunter
Latest: 2026-07-31
Prop Scan
Latest: 2026-07-31
60 appearances in last 60 days. First seen: 2026-06-15.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 18 · Vol —x
2026-08-20S2
Wk 18 · Vol —x
2026-08-19S2
Wk 18 · Vol —x
2026-08-18S2
Wk 17 · Vol —x
2026-08-17S2
Wk 17 · Vol —x
2026-08-14S2
Wk 17 · Vol —x
2026-08-13S2
Wk 17 · Vol —x
2026-08-12S2
Wk 17 · Vol —x
2026-08-11S2
Wk 16 · Vol —x
2026-08-10S2
Wk 16 · Vol —x
2026-08-07S2
Wk 16 · Vol —x
2026-08-06S2
Wk 16 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹287.5
200 DMA
₹255.3
52W High
₹344.8
52W Low
₹163.3
5D Low
₹250.7
Resistance levels (recent highs)
20d High
₹329.3
60d High
₹344.8
120d High
₹344.8
250d High
₹344.8
Next resistance
+24.3%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.